Oskar Franklin
@oskarfranklin.bsky.social
Umeå University Hospital 🇸🇪
Previous fellow University of Colorado 🇺🇸
Previous fellow University of Colorado 🇺🇸
Last week meeting with Bengt Ihre foundation marking the end of my Bengt Ihre research fellowship. Thanks for the support!
April 18, 2025 at 5:10 AM
Last week meeting with Bengt Ihre foundation marking the end of my Bengt Ihre research fellowship. Thanks for the support!
Reposted by Oskar Franklin
New paper published from our lab! Characterization of a new interferon-response CAFs with tumor-restraining properties.
aacrjournals.org/cancerres/ar...
aacrjournals.org/cancerres/ar...
Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibroblasts with Tumor-Restraining Properties
Abstract. Within the stroma of pancreatic ductal adenocarcinoma (PDAC), mesenchymal cells differentiate into cancer-associated fibroblast (CAF) subtypes that differentially mediate disease progression...
aacrjournals.org
April 11, 2025 at 6:08 PM
New paper published from our lab! Characterization of a new interferon-response CAFs with tumor-restraining properties.
aacrjournals.org/cancerres/ar...
aacrjournals.org/cancerres/ar...
Reposted by Oskar Franklin
Just came out: 📄 on cross-continent collaboration @ki.se on surgical outcome of #veinresection in #pancreaticcancer - a much disputed procedure:
authors.elsevier.com/c/1kWLp53tct...
My co-authors have not yet made the transition to the blue sky 🦋
authors.elsevier.com/c/1kWLp53tct...
My co-authors have not yet made the transition to the blue sky 🦋
bluesky.social.com
January 29, 2025 at 7:07 AM
Just came out: 📄 on cross-continent collaboration @ki.se on surgical outcome of #veinresection in #pancreaticcancer - a much disputed procedure:
authors.elsevier.com/c/1kWLp53tct...
My co-authors have not yet made the transition to the blue sky 🦋
authors.elsevier.com/c/1kWLp53tct...
My co-authors have not yet made the transition to the blue sky 🦋
Reposted by Oskar Franklin
PVR 1-2 vs 3-4 during pancreatoduodenectomy for resectable #PDAC with venous involvement?
In Annals of Surgery, our observational study with 357 patients from 🇸🇪🇯🇵🇳🇱🇺🇸:
📌PVR type NOT associated with OS, locoregional recurrence & major morbidity
➡️ surgeon’s personal preference
In Annals of Surgery, our observational study with 357 patients from 🇸🇪🇯🇵🇳🇱🇺🇸:
📌PVR type NOT associated with OS, locoregional recurrence & major morbidity
➡️ surgeon’s personal preference
January 23, 2025 at 4:33 PM
PVR 1-2 vs 3-4 during pancreatoduodenectomy for resectable #PDAC with venous involvement?
In Annals of Surgery, our observational study with 357 patients from 🇸🇪🇯🇵🇳🇱🇺🇸:
📌PVR type NOT associated with OS, locoregional recurrence & major morbidity
➡️ surgeon’s personal preference
In Annals of Surgery, our observational study with 357 patients from 🇸🇪🇯🇵🇳🇱🇺🇸:
📌PVR type NOT associated with OS, locoregional recurrence & major morbidity
➡️ surgeon’s personal preference
Reposted by Oskar Franklin
Our clinical/research fellow Dr Jun Yoshino from Institute of Science Tokyo is mastering real skiing! In january starting project on implementation of anatomical sketching in European HPB training 🇸🇪🇯🇵🇳🇴🇳🇱🇩🇪🇫🇷🇮🇹🇦🇹🇬🇧🇪🇺
January 11, 2025 at 7:11 AM
Our clinical/research fellow Dr Jun Yoshino from Institute of Science Tokyo is mastering real skiing! In january starting project on implementation of anatomical sketching in European HPB training 🇸🇪🇯🇵🇳🇴🇳🇱🇩🇪🇫🇷🇮🇹🇦🇹🇬🇧🇪🇺
Reposted by Oskar Franklin
On my way home from the 1st @PanCKI organized by @DhifafSarhan & @RainerHeuchel, starting with reception at @Stadshuset in Stockholm. Thank you for an amazing program & the kind invitation. @umeauniversity @oskarfranklin.bsky.social
November 20, 2024 at 8:43 PM
On my way home from the 1st @PanCKI organized by @DhifafSarhan & @RainerHeuchel, starting with reception at @Stadshuset in Stockholm. Thank you for an amazing program & the kind invitation. @umeauniversity @oskarfranklin.bsky.social